World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Vericel Corporation

    World Rank (Aug-2026)
    5,928
    Market Cap (Aug-2026)
    2.263 Billion USD
    World Rank (Jan-05-2024)
    6,459
    Market Cap (Jan-05-2024)
    1.623 Billion USD
    World Rank (Jul-30-2023)
    6,143
    Market Cap (Jul-30-2023)
    1.797 Billion USD
    World Rank (Dec-25-2022)
    7,816
    Market Cap (Dec-25-2022)
    1.125 Billion USD
    World Rank (Jan-07-2022)
    6,909
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    276 Million USD
    Annual Operating Income in USD
    11 Million USD
    Annual Net Income in USD
    17 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio pharmaceutical company with headquarters is in USA.
    Company Website
    VERICEL

  2. Anhui Anke Biotechnology (Group)

    World Rank (Aug-2026)
    5,981
    Market Cap (Aug-2026)
    2.224 Billion USD
    World Rank (Jan-05-2024)
    5,081
    Market Cap (Jan-05-2024)
    2.400 Billion USD
    World Rank (Jul-30-2023)
    4,984
    Market Cap (Jul-30-2023)
    2.472 Billion USD
    World Rank (Dec-25-2022)
    4,882
    Market Cap (Dec-25-2022)
    2.345 Billion USD
    World Rank (Jan-07-2022)
    4,470
    Market Cap (Jan-07-2022)
    3.36 Billion USD
    Annual Revenue in USD
    315 Million USD
    Annual Net Income in USD
    30 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    ANHUI ANKE BIOTECHNOLOGY (GROUP)

  3. Harmony Biosciences Holdings Inc.

    World Rank (Aug-2026)
    5,989
    Market Cap (Aug-2026)
    2.220 Billion USD
    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    868 Million USD
    Annual Operating Income in USD
    208 Million USD
    Annual Net Income in USD
    159 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

    Company Website
    HARMONY BIOSCIENCES HOLDINGS, INC.

  4. Bellus Health

    World Rank (Aug-2026)
    5,990
    World Rank (Jan-05-2024)
    5,990
    World Rank (Jul-30-2023)
    5,990
    Market Cap (Jul-30-2023)
    1.870 Billion USD
    World Rank (Dec-25-2022)
    7,834
    Market Cap (Dec-25-2022)
    1.121 Billion USD
    World Rank (Jan-07-2022)
    11,402
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Headquarters Country
    Canada
    Company Profile

    BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Headquarters is in Canada.

    Company Website
    BELLUS HEALTH

  5. Biohaven Pharmaceutical Holding Company

    World Rank (Aug-2026)
    6,000
    Market Cap (Aug-2026)
    2.211 Billion USD
    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    -704 Million USD
    Annual Net Income in USD
    -847 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

    Company Website
    BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

  6. Ocular Therapeutix

    World Rank (Aug-2026)
    6,015
    Market Cap (Aug-2026)
    2.205 Billion USD
    World Rank (Jan-05-2024)
    12,314
    Market Cap (Jan-05-2024)
    0.523 Billion USD
    World Rank (Jul-30-2023)
    14,969
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    17,875
    Market Cap (Dec-25-2022)
    0.206 Billion USD
    World Rank (Jan-07-2022)
    13,549
    Market Cap (Jan-07-2022)
    0.49 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -270 Million USD
    Annual Net Income in USD
    -266 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ocular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.
    Company Website
    OCULAR THERAPEUTIX

  7. Nuvation Bio Inc.

    World Rank (Aug-2026)
    6,043
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,248
    Market Cap (Jan-05-2024)
    0.327 Billion USD
    World Rank (Jul-30-2023)
    14,372
    Market Cap (Jul-30-2023)
    0.385 Billion USD
    World Rank (Dec-25-2022)
    14,104
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    7,508
    Market Cap (Jan-07-2022)
    1.47 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Operating Income in USD
    -213 Million USD
    Annual Net Income in USD
    -205 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Nuvation Bio is a Biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. The headquarters is in USA.

    Company Website
    NUVATION BIO INC.

  8. Precigen Inc.

    World Rank (Aug-2026)
    6,044
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,259
    Market Cap (Jan-05-2024)
    0.326 Billion USD
    World Rank (Jul-30-2023)
    15,121
    Market Cap (Jul-30-2023)
    0.341 Billion USD
    World Rank (Dec-25-2022)
    15,801
    Market Cap (Dec-25-2022)
    0.296 Billion USD
    World Rank (Jan-07-2022)
    11,639
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -111 Million USD
    Annual Net Income in USD
    -251 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders and infectious diseases. The company annual revenue is 103 million USD as on 2020. The headquarters is in USA.
    Company Website
    PRECIGEN, INC.

  9. SK Bioscience Co. Ltd

    World Rank (Aug-2026)
    6,135
    Market Cap (Aug-2026)
    2.124 Billion USD
    World Rank (Jan-05-2024)
    3,380
    Market Cap (Jan-05-2024)
    4.182 Billion USD
    World Rank (Jul-30-2023)
    3,335
    Market Cap (Jul-30-2023)
    4.352 Billion USD
    World Rank (Dec-25-2022)
    2,897
    Market Cap (Dec-25-2022)
    4.672 Billion USD
    World Rank (Jan-07-2022)
    1,473
    Market Cap (Jan-07-2022)
    13.59 Billion USD
    Annual Revenue in USD
    756 Million USD
    Annual Net Income in USD
    289 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    South Korea
    CEO
    Ahn Jae-yong
    Company Profile

    Biotechnology sector company with advanced vaccine R&D technology and productivity. Headquarters is in South Korea.

    Company Website
    SK BIOSCIENCE CO.,LTD.

  10. ADMA Biologics

    World Rank (Aug-2026)
    6,140
    Market Cap (Aug-2026)
    2.121 Billion USD
    World Rank (Jan-05-2024)
    8,463
    Market Cap (Jan-05-2024)
    1.024 Billion USD
    World Rank (Jul-30-2023)
    9,311
    Market Cap (Jul-30-2023)
    0.896 Billion USD
    World Rank (Dec-25-2022)
    9,556
    Market Cap (Dec-25-2022)
    0.806 Billion USD
    World Rank (Jan-07-2022)
    17,664
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    510 Million USD
    Annual Operating Income in USD
    191 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ADMA BIOLOGICS

Share